carbidopa has been researched along with Movement Disorders in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 39 (54.93) | 18.7374 |
1990's | 20 (28.17) | 18.2507 |
2000's | 6 (8.45) | 29.6817 |
2010's | 5 (7.04) | 24.3611 |
2020's | 1 (1.41) | 2.80 |
Authors | Studies |
---|---|
Artusi, CA; Imbalzano, G; Ledda, C; Lopiano, L; Montanaro, E; Rizzone, MG; Romagnolo, A; Zibetti, M | 1 |
Băjenaru, O; Buraga, I; Constantinescu, A; Ene, A; Mureşan, DF; Perju-Dumbrava, L; Popescu, BO; Popescu, CD; Sabău, M; Simu, M; Szász, JA | 1 |
Hattori, N | 1 |
Delgado, MR; Donovan, MA; Jou, RL; Kang, PB; Kim, SY; Neilan, EG; Wu, BL | 1 |
Dugan, EA; Hayashi, Y; Jacob-Vadakot, S; McBride, S; Murray, M; Olexa, R; Shumsky, JS; Simansky, K | 1 |
Fisher, R; Jackson, MJ; Jenner, P; Rose, S; Tayarani-Binazir, KA; Zoubiane, G | 1 |
Armstrong, J; Artuch, R; Barredo-Valderrama, E; Campistol, J; Castro de Castro, P; Cormand, B; Garcia-Cazorla, A; Ormazabal, A; Serrano, M; Toma, C | 1 |
Gadkary, CA; Mummaneni, PV; Quinones-Hinojosa, A; Rosenberg, WS | 1 |
Blau, N; Connolly, MB; Demos, MK; Hyland, K; Lillquist, Y; Makhseed, N; Vallance, HD; Waters, PJ | 1 |
Crucian, GP; Drago, V; Foster, PS; Heilman, KM; Skidmore, F; Skoblar, BM | 1 |
Albizzati, MG; Bassi, S; Frattola, L; Spano, PF; Trabucchi, M | 1 |
Ballard, P; Langston, JW | 1 |
Casey, DE | 1 |
Bentlage, C; Björklund, A; Nikkhah, G; Olsson, M | 1 |
Donat, J; Gerrard, JW; Richardson, JS | 1 |
Brin, IL; Drozdov, AZ; Filatova, TS; Kogan, BM; Kovaleva, IA | 1 |
Broe, GA; Hely, MA; Margrie, S; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM | 1 |
Atchison, PR; Frackowiak, RS; Marsden, CD; Thompson, PD | 1 |
Bennett, JP; Schuh, LA | 1 |
Imai, H; Kondo, T; Nakamura, T; Narabayashi, H | 1 |
Horstink, MW; Jansen, EN; Roos, RA; Wolters, EC | 1 |
Date, ES; Schwartz, M; Seibel, MO; Zeiner, H | 1 |
Caraceni, T; Fetoni, V; Geminiani, GC; Genitrini, S; Giovannini, P; Girotti, F; Parati, EA; Soliveri, P; Testa, D | 1 |
Campistol, J; Garaizar, C; Prats, JM | 1 |
Burns, RS; Davis, TL; Roznoski, M | 1 |
Dubinsky, R; Hubble, JP; Koller, WC; Lyons, K; McGuire, D; Pahwa, R | 1 |
Carvey, PM; Goetz, CG; Ling, ZD; Niederman, F; Pappert, EJ; Stebbins, GT | 1 |
Carter, JH; Lea, ES; Nutt, JG; Woodward, WR | 1 |
Blaney, TJ; Chandonait, SE; Emerich, DF; Lindner, MD; Mullins, TD; Plone, MA; Sherman, SS; Stott, JA; Winn, SR | 1 |
Gordin, A; Jenner, P; Marsden, CD; Smith, LA | 1 |
Ellis, KL; Speed, J | 1 |
Hempel, AG; Maaty, MA; Sage, JI; Wagner, ML | 1 |
Ahangar, B; Burke, DT; Chae, H; Frates, EP | 1 |
Elsworth, JD; Kohout, LJ; Lees, AJ; Sandler, M; Shaw, KM; Stern, GM; Youdim, MB | 1 |
Sears, ES | 1 |
Fahn, S | 2 |
Anders, TF; Barchas, JD; Berger, PA; Cann, HM; Ciaranello, RD | 1 |
Adamkov, J; Drobný, M; Fundárek, J; Svaleková, A | 1 |
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
Fisher, MA; Milner-Brown, HS; Weiner, WJ | 1 |
Hayek, J | 1 |
Duvoisin, RC | 1 |
Gabreëls, FJ; Joosten, EM; Keyser, A; Korten, JJ | 1 |
Marsden, CD; Parkes, JD; Tarsy, D | 1 |
Goodgold, A; Jonas, S; Leibowitz, M; Lieberman, A | 1 |
Bell-Midura, M; Cotzias, GC; Mendez, JS; Papavasiliou, PS; Tolosa, ES | 1 |
Kishikawa, H; Ohmoto, T | 1 |
Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ | 1 |
Löscher, W; Pagliusi, SR | 1 |
Butler, IJ; Caskey, TC; Jankovic, J; Stout, JT | 1 |
Deleu, D; Ebinger, G; Jacques, M; Michotte, Y | 1 |
Gilley, DW; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
Dickins, QS; Dobson, J; Rodnitzky, RL | 1 |
Bush, DF; Hutton, JT; Liss, CL; Morris, JL; Reines, S; Smith, ME | 1 |
Reynolds, CM; Riklan, M; Stellar, S | 1 |
Simpson, GM; Stephanos, MJ; Yadalam, KG | 1 |
Bioulac, B; Doudet, D; Gross, C; Lebrun-Grandié, P | 1 |
Agnoli, A; Brughitta, G; Ruggieri, S; Stocchi, F | 1 |
Hoerning, E; Kaplan, PE; Sohn, DG | 1 |
Bakker, K; Bruno, G; Chase, TN; Ruggieri, S; Tamminga, CA | 1 |
Calne, DB; Jaffe, M; Larsen, TA; LeWitt, PA; Newman, RP | 1 |
Benvenuti, F; Bindi, A; Costantini, S; De Scisciolo, G; Pantaleo, T; Rossi, L; Zappoli, R | 1 |
Chase, TN; Woods, AC | 1 |
Glasgow, GL; Henley, JW; Willoughby, EW | 1 |
Cotzias, GC; Mena, I; Papavasiliou, PS | 1 |
Markham, CH | 1 |
Andrews, CJ; Somerville, B | 1 |
Brody, JA; Chase, TN; Holden, EM | 1 |
Duvoisin, RC; Marsden, CD | 1 |
4 review(s) available for carbidopa and Movement Disorders
Article | Year |
---|---|
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review.
Topics: Carbidopa; COVID-19; COVID-19 Vaccines; Deep Brain Stimulation; Drug Combinations; Humans; Immunization, Secondary; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Treatment Outcome; Vaccination | 2022 |
Movement disorders: advances in 2015.
Topics: Animals; Antiparkinson Agents; Carbidopa; DNA-Binding Proteins; Drug Combinations; Humans; Levodopa; Mitochondrial Proteins; Movement Disorders; Parkinson Disease; Transcription Factors | 2016 |
Entacapone/levodopa/carbidopa combination tablet: Stalevo.
Topics: Administration, Oral; Antiparkinson Agents; Carbidopa; Catechols; Clinical Trials as Topic; Drug Combinations; Humans; Levodopa; Movement Disorders; Nitriles; Parkinson Disease; Tablets | 2003 |
The syndrome of gait ignition failure: a report of six cases.
Topics: Aged; Benserazide; Brain; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease; Syndrome; Tomography, X-Ray Computed | 1993 |
18 trial(s) available for carbidopa and Movement Disorders
Article | Year |
---|---|
Greater motor improvement in right hemibody Parkinson's patients after dopaminergic medications.
Topics: Aged; Analysis of Variance; Carbidopa; Dopamine Agents; Female; Functional Laterality; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease | 2009 |
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure | 1994 |
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease | 1993 |
Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegiline.
Topics: Aged; Antiparkinson Agents; Benzophenones; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Movement Disorders; Nitrophenols; Parkinson Disease; Selegiline; Tolcapone | 1995 |
Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.
Topics: Aged; Carbidopa; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Dihydroxyphenylalanine; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1996 |
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation.
Topics: Adult; Aged; Carbidopa; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders | 1996 |
Pharmacoeconomic analysis of using Sinemet CR over standard Sinemet in parkinsonian patients with motor fluctuations.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies | 1998 |
Deprenyl in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Phenethylamines | 1977 |
Madopar versus sinemet. A clinical study on their effectiveness.
Topics: Adult; Aged; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Serine | 1975 |
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine | 1975 |
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease | 1975 |
Treatment of Parkinson's disease with aporphines. Possible role of growth hormone.
Topics: Administration, Oral; Aged; Apomorphine; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Growth Hormone; Humans; Kidney; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Secretory Rate | 1976 |
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Movement Disorders; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic | 1989 |
Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Random Allocation | 1988 |
Caerulein treatment of Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Ceruletide; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1985 |
Motor function in the normal aging population: treatment with levodopa.
Topics: Aged; Aging; Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Parkinson Disease | 1985 |
L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
Topics: Aged; Blood Pressure; Carbidopa; Clinical Trials as Topic; Depression, Chemical; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos; Posture; Vomiting | 1974 |
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos | 1974 |
49 other study(ies) available for carbidopa and Movement Disorders
Article | Year |
---|---|
The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastric Bypass; Gels; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Quality of Life; Retrospective Studies; Romania | 2016 |
Response of motor complications in Cockayne syndrome to carbidopa-levodopa.
Topics: Adolescent; Carbidopa; Cockayne Syndrome; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Movement Disorders | 2008 |
5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Cervical Vertebrae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Enzyme Inhibitors; Exercise Test; Exploratory Behavior; Female; Fenfluramine; Hindlimb; Laminectomy; Motor Activity; Movement Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Spinal Cord Injuries; Stereotyped Behavior; Time Factors; Tremor; Up-Regulation | 2010 |
The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Callithrix; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Levodopa; Male; Methyldopa; Motor Activity; Movement Disorders | 2010 |
Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype.
Topics: Antiparkinson Agents; Carbidopa; DNA Mutational Analysis; Drug Combinations; Female; Homovanillic Acid; Humans; Infant; Levodopa; Movement Disorders; Phenotype; Sequence Deletion; Tyrosine 3-Monooxygenase; Video Recording | 2011 |
Split spinal cord malformation in an elderly patient: case report.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Carbidopa; Clonazepam; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Low Back Pain; Magnetic Resonance Imaging; Movement Disorders; Spinal Dysraphism; Tomography, X-Ray Computed | 2004 |
6-pyruvoyl-tetrahydropterin synthase deficiency with mild hyperphenylalaninemia.
Topics: 5-Hydroxytryptophan; Biopterins; Carbidopa; Cerebral Palsy; Child; Developmental Disabilities; Diagnostic Errors; Dopamine Agents; Female; Humans; Levodopa; Movement Disorders; Phenylalanine; Phenylketonurias; Phosphorus-Oxygen Lyases; Seizures | 2005 |
Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.
Topics: Aged; Carbidopa; Dystonia; Ergolines; Female; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1980 |
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Carbidopa; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Pyridines | 1984 |
Pharmacology of blepharospasm-oromandibular dystonia syndrome.
Topics: Aged; Benztropine; Blepharospasm; Carbidopa; Deanol; Drug Therapy, Combination; Electromyography; Eyelid Diseases; Humans; Jaw Diseases; Levodopa; Male; Middle Aged; Movement Disorders; Syndrome | 1980 |
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Carbidopa; Dextroamphetamine; Disease Models, Animal; Dopamine; Dopamine Agonists; Ergolines; Female; Fetal Tissue Transplantation; Forelimb; Functional Laterality; Levodopa; Motor Activity; Movement Disorders; Norepinephrine; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Transplantation, Heterotopic | 1995 |
Neuropharmacological evaluation of movement disorders that are adverse reactions to specific foods.
Topics: Adult; Animals; Aspartame; Carbidopa; Coffee; Diazepam; Double-Blind Method; Eggs; Female; Food Hypersensitivity; Haloperidol; Humans; Male; Milk; Milk Hypersensitivity; Movement Disorders; Propranolol; Single-Blind Method; Theophylline; Videotape Recording | 1994 |
[Catecholamines and the dopamine-beta-hydroxylase activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms].
Topics: Adolescent; Carbidopa; Catecholamines; Child; Chromatography, High Pressure Liquid; Dopamine Agonists; Dopamine beta-Hydroxylase; Drug Combinations; Female; Humans; Levodopa; Male; Movement Disorders; Spectrophotometry | 1994 |
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tyrosine | 1993 |
Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
Topics: Benserazide; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Movement Disorders; Neurologic Examination; Ocular Motility Disorders; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive | 1993 |
Rehabilitation of patients with Hallervorden-Spatz syndrome.
Topics: Activities of Daily Living; Adult; Carbidopa; Drug Therapy, Combination; Exercise Therapy; Humans; Levodopa; Male; Movement Disorders; Pantothenate Kinase-Associated Neurodegeneration; Patient Care Team | 1993 |
Response to L-DOPA in multiple system atrophy.
Topics: Adult; Aged; Carbidopa; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Movement Disorders; Muscle Rigidity; Olivopontocerebellar Atrophies; Parkinson Disease; Tremor | 1993 |
Benign paroxysmal tonic upgaze of childhood with ataxia. A neuro-ophthalmological syndrome of familial origin?
Topics: Age Factors; Ataxia; Carbidopa; Eye Movements; Family; Humans; Infant; Levodopa; Male; Movement Disorders; Ocular Motility Disorders; Posture; Sleep; Syndrome | 1993 |
Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.
Topics: Adult; Aged; Amino Acids; Antiparkinson Agents; Brain; Carbidopa; Circadian Rhythm; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Severity of Illness Index; Time Factors | 1997 |
Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carbidopa; Cell Transplantation; Disease Models, Animal; Dopamine; Drug Combinations; Drug Synergism; Levodopa; Male; Movement Disorders; Neostriatum; Parkinson Disease, Secondary; PC12 Cells; Rats; Rats, Sprague-Dawley; Rotation | 1997 |
Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Carbidopa; Catechols; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Levodopa; Male; Movement Disorders; Nitriles; Severity of Illness Index | 1997 |
Pharmacologic management of movement disorder after midbrain haemorrhage.
Topics: Activities of Daily Living; Adult; Brain Neoplasms; Carbidopa; Cavernous Sinus; Central Nervous System Stimulants; Cerebral Hemorrhage; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hemangioma, Cavernous; Humans; Levodopa; Male; Mesencephalon; Methamphetamine; Movement Disorders; Substance-Related Disorders | 1998 |
Post-stroke violent adventitial movement responsive to levo-dopa/carbi-dopa therapy.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Basal Ganglia; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Movement Disorders; Stroke; Treatment Outcome; Tremor | 2001 |
Therapeutics of disordered movement.
Topics: Carbidopa; Chorea; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease; Receptors, Cholinergic; Receptors, Dopamine; Tremor | 1977 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclonus; Propranolol; Receptors, Dopamine; Torticollis; Tranquilizing Agents; Tremor | 1977 |
Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.
Topics: 5-Hydroxytryptophan; Carbidopa; Child; Drug Therapy, Combination; Humans; Hydrazines; Lesch-Nyhan Syndrome; Male; Movement Disorders; Self Mutilation; Sleep; Wakefulness | 1978 |
[Therapy of rigidity and hypokinesis in old age using Sinemet].
Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Muscle Rigidity; Parkinson Disease, Postencephalitic; Trihexyphenidyl | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
Electrical properties of motor units in Parkinsonism and a possible relationship with bradykinesia.
Topics: Action Potentials; Adult; Aged; Carbidopa; Electromyography; Forearm; Gait; Hand; Humans; Levodopa; Male; Middle Aged; Motor Skills; Movement Disorders; Muscle Contraction; Muscles; Neuromuscular Junction; Parkinson Disease; Recruitment, Neurophysiological | 1979 |
[Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
Topics: Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Parkinson Disease; Psychoses, Substance-Induced | 1977 |
Problems in the treatment of Parkinsonism.
Topics: Antiparkinson Agents; Arteriosclerosis; Carbidopa; Diagnosis, Differential; Drug Combinations; Eye Manifestations; Humans; Levodopa; Mental Disorders; Movement Disorders; Parasympatholytics; Paresthesia; Parkinson Disease; Vision Disorders | 1977 |
L-dopa therapy combined with peripheral decarboxylase inhibitor (MK-486) in Parkinsonism.
Topics: Adult; Aged; Animals; Carbidopa; Carboxy-Lyases; Cats; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Injections, Intraperitoneal; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1975 |
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord | 1992 |
Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Body Weight; Brain Chemistry; Carbidopa; Drug Interactions; Drug Tolerance; Female; Hydroxyindoleacetic Acid; Movement Disorders; Rats; Rats, Inbred Strains; Seizures; Serotonin | 1985 |
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
Topics: Carbidopa; Catecholamines; Child; Child, Preschool; Fluphenazine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lesch-Nyhan Syndrome; Levodopa; Male; Methoxyhydroxyphenylglycol; Movement Disorders; Self Mutilation; Tetrabenazine | 1988 |
Clinical and pharmacokinetic evaluation of controlled-release levodopa/carbidopa (CR-4) in parkinsonian patients with severe motor fluctuations: a six month follow-up study.
Topics: Adult; Aged; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1989 |
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Psychomotor Performance | 1989 |
Long-term clinical efficacy of Sinemet CR in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease | 1989 |
Correlates of memory in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Memory; Memory Disorders; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease | 1989 |
[A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Carbidopa; Disease Models, Animal; Drug Combinations; Electromyography; Levodopa; Macaca mulatta; Movement Disorders; Parkinson Disease, Secondary; Pyridines | 1985 |
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Topics: Administration, Oral; Adult; Aged; Carbidopa; Domperidone; Ergolines; Female; Humans; Infusions, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1986 |
Carbidopa-levodopa therapy for movement disorders.
Topics: Basal Ganglia Diseases; Carbidopa; Craniocerebral Trauma; Drug Therapy, Combination; Humans; Levodopa; Movement Disorders | 1987 |
Auditory and somatosensory evoked potentials (AEPs and SEPs) and ballistic movements in Parkinson disease.
Topics: Aged; Carbidopa; Drug Therapy, Combination; Electromyography; Evoked Potentials, Auditory; Evoked Potentials, Somatosensory; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1985 |
M.I.F.: effect on levodopa dyskinesias in man.
Topics: Antiparkinson Agents; Carbidopa; Carboxy-Lyases; Decarboxylation; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Humans; Melanocyte-Stimulating Hormones; Methylation; Movement Disorders; Parkinson Disease | 1973 |
Short- and long-term approaches to the "on-off" phenomenon.
Topics: Apomorphine; Carbidopa; Dietary Proteins; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Time Factors | 1974 |
The "on-off" side effect of L-DOPA.
Topics: Age Factors; Amitriptyline; Aromatic Amino Acid Decarboxylase Inhibitors; Athetosis; Carbidopa; Catechol O-Methyltransferase Inhibitors; Chlordiazepoxide; Chorea; Desipramine; Diazepam; Dietary Proteins; Enzyme Inhibitors; Female; Humans; Imipramine; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Physical Exertion; Picolinic Acids; Prochlorperazine; Sex Factors; Stress, Psychological | 1974 |
Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Carbidopa; Dementia; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1973 |
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Methyldopa; Mice; Movement Disorders; Parkinson Disease; Phenoxybenzamine; Pimozide; Reserpine | 1974 |
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Injections, Intramuscular; Male; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Pyridoxine | 1974 |